Close Menu

NEW YORK (GenomeWeb) – A team of researchers from Columbia University, Northwestern University School of Medicine, and elsewhere has identified tumor and microenvironment features in glioblastoma (GBM) brain tumors that are linked to response to immune checkpoint immunotherapy targeting PD-1.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.


This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.